Results from the BASAL-BALI study showed that switching persons with T2DM who were inadequately controlled on human insulins to basal insulin analogues was associated with significant improvement in glycemic control, measured in terms of reduction in HbA1c and FPG levels. This evidence concerns the gene INS and type 2 diabetes mellitus.